Sonova Holding AG (PHBN.HA)
| Previous Close | 196.05 |
| Open | 202.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 202.70 - 202.70 |
| 52 Week Range | 194.75 - 202.70 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ReutersSonova's profit warning less severe than feared; shares jump 7%
Sonova's shares jumped more than 7% early on Tuesday after the Swiss hearing aid maker's downward adjustment of full-year core earnings estimates was less severe than investors had feared. The world's largest maker of hearing aids expects its annual adjusted core earnings (EBITA) to grow between 4% and 8% in local currency, compared with a previous target of 6% to 10%. "Shares are trading up, most likely because there is a relief in the market that the profit warning was not bigger than what it turned out to be," Carnegie analyst Niels Granholm Leth said.
ReutersSonova full-year profit falls short after loses big US client
Sonova Holding AG, the world's largest maker of hearing aids, on Tuesday reported full-year core profit below expectations and said a return to "normal growth rates" would take time given weak consumer sentiment and the loss of a big US customer. The Swiss group posted adjusted earnings before interest, tax and amortization (EBITA) of 840.4 million francs ($945.44 million) for the fiscal year ended March 31, missing analysts' forecasts of 859.7 million francs in a poll by Vara Research. Sonova said it expected 2023-2024 consolidated sales to increase 3%-7% and adjusted EBITA to grow in the range of 6% to 10%, measured at constant-exchange rates.
